Liver cancer remains a challenge of global health, being the 4 th leading cause of cancer
death worldwide. Hepatocellular carcinoma (HCC) is the most common type of primary liver …

Liver cancer remains a challenge of global health, being the 4th leading cause of cancer
death worldwide. Hepatocellular carcinoma (HCC) is the most common type of primary liver …

Hepatocellular carcinoma (HCC) is a chronic liver disease that is highly fatal if not detected
and treated early. The incidence and death rate of HCC have been increasing in recent …

Recent advances in the treatment of hepatocellular carcinoma : Current Opinion in
Gastroenterology Recent advances in the treatment of hepatocellular carcinoma : Current …

There have been advances in HCC treatment options over the last couple of years and there
are now potential therapies for most patients with any stage of disease. Treatment decisions …

Hepatocellular carcinoma (HCC) is a highly lethal disease that is resistant to conventional
cytotoxic drugs. Historically, effective systemic treatment options have not been available for …

Hepatocellular carcinoma (HCC) is the fifth most common cancer and it is the third leading
cause of cancer-related deaths worldwide. Once diagnosed with the disease, only 30-40 …

A concordance of multiple advances is changing the management of hepatocellular
carcinoma (HCC). These include:(1) identification of preventable and treatable causal …

Heptatocellular (HCC) is a rapidly progressive fatal malignancy often presenting at an
advanced stage at the time of initial diagnosis. Loco-regional therapies for early-stage HCC …

Liver cancer, mostly hepatocellular carcinoma (HCC), is the second leading cause of cancer
mortality globally. Most patients need at least one systemic therapy at different phases of …